{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:25:30Z","timestamp":1794025530995,"version":"4.8.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100018227","name":"National Research Foundation of Ukraine","doi-asserted-by":"publisher","award":["2023.03\/0176 \u00abStrategy for directed synthesis of functional chalcogen halide materials for medical and energy needs\u00bb"],"award-info":[{"award-number":["2023.03\/0176 \u00abStrategy for directed synthesis of functional chalcogen halide materials for medical and energy needs\u00bb"]}],"id":[{"id":"10.13039\/100018227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018227","name":"National Research Foundation of Ukraine","doi-asserted-by":"publisher","award":["2023.03\/0176 \u00abStrategy for directed synthesis of functional chalcogen halide materials for medical and energy needs\u00bb"],"award-info":[{"award-number":["2023.03\/0176 \u00abStrategy for directed synthesis of functional chalcogen halide materials for medical and energy needs\u00bb"]}],"id":[{"id":"10.13039\/100018227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36386-5","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:23:17Z","timestamp":1768634597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bis-1,2,4-triazole derivatives as potential antioxidants for pneumonia therapy"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7155-1676","authenticated-orcid":false,"given":"Nataliya","family":"Korol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9948-1742","authenticated-orcid":false,"given":"Olesia","family":"Symkanych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3636-6621","authenticated-orcid":false,"given":"Oleksandra","family":"Pallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4788-0511","authenticated-orcid":false,"given":"Mikhailo","family":"Slivka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5357-7562","authenticated-orcid":false,"given":"Ondrej","family":"Slanar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"key":"36386_CR1","unstructured":"World Health Organization. Pneumonia. World Health Organization. Available online: (2023). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/pneumonia (accessed May 2025)."},{"key":"36386_CR2","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1164\/rccm.201010-1755OC","volume":"183","author":"YM Hosakote","year":"2011","unstructured":"Hosakote, Y. M. et al. Viral-mediated Inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am. J. Respir Crit. Care Med. 183, 1550\u20131560 (2011).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"36386_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-3-319-63245-2_8","volume":"967","author":"M Kellner","year":"2017","unstructured":"Kellner, M. et al. ROS signaling in the pathogenesis of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Adv. Exp. Med. Biol. 967, 105\u2013137 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"36386_CR4","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s12192-023-01330-3","volume":"28","author":"M Tepeba\u015f\u0131","year":"2023","unstructured":"Tepeba\u015f\u0131, M. et al. Investigation of inflammation, oxidative stress, and DNA damage in patients with severe pneumonia. Cell. Stress Chaperones. 28, 865\u2013875 (2023).","journal-title":"Cell. Stress Chaperones"},{"key":"36386_CR5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s43094-024-00638-w","volume":"10","author":"M Youssef","year":"2024","unstructured":"Youssef, M. et al. Antioxidants as adjuvant therapy in the treatment of community-acquired pneumonia. Future J. Pharm. Sci. 10, 67 (2024).","journal-title":"Future J. Pharm. Sci."},{"key":"36386_CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14218\/ERHM.2023.00039","volume":"9","author":"E \u00d6zen\u00e7","year":"2024","unstructured":"\u00d6zen\u00e7, E. et al. Relationship between concentrations of oxygen and levels of oxidative stress in patients receiving oxygen therapy for severe COVID-19 pneumonia. Explor. Res. Hypothesis Med. 9, 15\u201322 (2024).","journal-title":"Explor. Res. Hypothesis Med."},{"key":"36386_CR7","first-page":"11","volume":"2","author":"MEH Kayesh","year":"2025","unstructured":"Kayesh, M. E. H., Tsukiyama-Kohara, K. & Kohara, M. Effects of oxidative stress on viral infections: an overview. Npj Infect. Dis. 2, 11 (2025).","journal-title":"Npj Infect. Dis."},{"key":"36386_CR8","first-page":"123","volume":"216","author":"L Juh\u00e1sz","year":"2025","unstructured":"Juh\u00e1sz, L. et al. Oxidative stress and PARP activation in the lungs is an underlying mechanism in lung injury. Free Radic Biol. Med. 216, 123\u2013137 (2025).","journal-title":"Free Radic Biol. Med."},{"key":"36386_CR9","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.1039\/C6OB00936K","volume":"14","author":"AP Taylor","year":"2016","unstructured":"Taylor, A. P. et al. Modern advances in heterocyclic chemistry in drug discovery. Org. Biomol. Chem. 14, 6611\u20136637 (2016).","journal-title":"Org. Biomol. Chem."},{"key":"36386_CR10","doi-asserted-by":"publisher","first-page":"44247","DOI":"10.1039\/D0RA09198G","volume":"10","author":"MM Heravi","year":"2020","unstructured":"Heravi, M. M. & Zadsirjan, V. Prescribed drugs containing nitrogen heterocycles: an overview. RSC Adv. 10, 44247\u201344311 (2020).","journal-title":"RSC Adv."},{"key":"36386_CR11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ejmech.2014.11.033","volume":"97","author":"\u015eG K\u00fc\u00e7\u00fckg\u00fczel","year":"2015","unstructured":"K\u00fc\u00e7\u00fckg\u00fczel, \u015e. G. & \u00c7\u0131kla-S\u00fczg\u00fcn, P. Recent advances in bioactive 1,2,4-triazole-3-thiones. Eur. J. Med. Chem. 97, 830\u2013870 (2015).","journal-title":"Eur. J. Med. Chem."},{"key":"36386_CR12","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1002\/jhet.4044","volume":"57","author":"MV Slivka","year":"2020","unstructured":"Slivka, M. V., Korol, N. I. & Fizer, M. M. Fused bicyclic 1,2,4-triazoles with one extra sulfur atom: synthesis, properties, and biological activity. J. Heterocycl. Chem. 57, 3236\u20133254 (2020).","journal-title":"J. Heterocycl. Chem."},{"key":"36386_CR13","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3390\/app14051695","volume":"14","author":"M Kadela-Tomanek","year":"2024","unstructured":"Kadela-Tomanek, M. et al. Assessment of bioavailability parameters of mono- and Bistriazole derivatives of Propynoylbetulin. Appl. Sci. 14, 1695 (2024).","journal-title":"Appl. Sci."},{"key":"36386_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1515\/hc-2022-0174","volume":"30","author":"P Goyal","year":"2024","unstructured":"Goyal, P. et al. Synthetic and therapeutic review of Triazoles and hybrids. Heterocycl. Commun. 30, 157\u2013176 (2024).","journal-title":"Heterocycl. Commun."},{"key":"36386_CR15","first-page":"145","volume":"15","author":"D Dowerah","year":"2024","unstructured":"Dowerah, D. et al. Bis-aryl Triazole trehalolipids are mincle agonists. ACS Med. Chem. Lett. 15, 145\u2013152 (2024).","journal-title":"ACS Med. Chem. Lett."},{"key":"36386_CR16","doi-asserted-by":"publisher","first-page":"106676","DOI":"10.1016\/j.bioorg.2023.106676","volume":"137","author":"P Li","year":"2023","unstructured":"Li, P. et al. Review of Triazole scaffolds for treatment and diagnosis. Bioorg. Chem. 137, 106676 (2023).","journal-title":"Bioorg. Chem."},{"key":"36386_CR17","first-page":"11250","volume":"14","author":"MM Heravi","year":"2024","unstructured":"Heravi, M. M. & Zadsirjan, V. Significance of Triazole in medicinal chemistry. RSC Adv. 14, 11250\u201311278 (2024).","journal-title":"RSC Adv."},{"key":"36386_CR18","first-page":"93","volume":"16","author":"NI Korol","year":"2023","unstructured":"Korol, N. I. et al. Synthesis, biological evaluation and molecular Docking studies of novel series of bis-1,2,4-triazoles as thymidine phosphorylase inhibitors. Adv. Appl. Bioinform Chem. 16, 93\u2013102 (2023).","journal-title":"Adv. Appl. Bioinform Chem."},{"key":"36386_CR19","first-page":"e1403","volume":"9","author":"SB Zaman","year":"2019","unstructured":"Zaman, S. B. et al. A review on antibiotic resistance: alarm bells are ringing. Cureus 9, e1403 (2019).","journal-title":"Cureus"},{"key":"36386_CR20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3389\/fcimb.2018.00393","volume":"8","author":"A Ullah","year":"2018","unstructured":"Ullah, A., Khan, A. & Khan, A. Antibiotic resistance in Campylobacter: a review. Front. Cell. Infect. Microbiol. 8, 393 (2018).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"36386_CR21","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/1811199a0","volume":"181","author":"MS Blois","year":"1958","unstructured":"Blois, M. S. Antioxidant determinations by the use of a stable free radical. Nature 181, 1199\u20131200 (1958).","journal-title":"Nature"},{"key":"36386_CR22","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.foodchem.2008.08.008","volume":"113","author":"OP Sharma","year":"2009","unstructured":"Sharma, O. P. & Bhat, T. K. DPPH antioxidant assay revisited. Food Chem. 113, 1202\u20131205 (2009).","journal-title":"Food Chem."},{"key":"36386_CR23","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"36386_CR24","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires, D. E., Blundell, T. L. & Ascher, D. B. PkCSM: predicting small-molecule Pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58, 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"36386_CR25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/jmbi.1999.3044","volume":"292","author":"A Adler","year":"1999","unstructured":"Adler, A., Tarshis, M. & Arad, D. Crystal structure of Streptococcus pneumoniae neuraminidase A (NanA) at 2.4 \u00c5 resolution. J. Mol. Biol. 292, 345\u2013356 (1999).","journal-title":"J. Mol. Biol."},{"key":"36386_CR26","first-page":"261","volume":"21","author":"HM Marriott","year":"2008","unstructured":"Marriott, H. M., Mitchell, T. J. & Dockrell, D. H. Pneumolysin: a double-edged sword during the host-pathogen interaction. Curr. Opin. Infect. Dis. 21, 261\u2013266 (2008).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"36386_CR27","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock 4 and autodocktools: automated Docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"36386_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"36386_CR29","unstructured":"Dassault & Syst\u00e8mes Discovery Studio 2021 Visualizer (Dassault Syst\u00e8mes, 2021)."},{"key":"36386_CR30","first-page":"640","volume":"98","author":"MH Hussin","year":"2017","unstructured":"Hussin, M. H., Rahim, A. A., Ibrahim, M. N. M. & Brosse, N. The effect of p-nitrophenol toward the structural characteristics and antioxidant activity of oil palm fronds (OPF) lignin polymers. Int. J. Biol. Macromol. 98, 640\u2013650 (2017).","journal-title":"Int. J. Biol. Macromol."},{"key":"36386_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijantimicag.2005.04.020","volume":"26","author":"FR Champlin","year":"2005","unstructured":"Champlin, F. R., Ellison, M. L., Bullard, J. W. & Conrad, R. S. Effect of outer membrane permeabilisation on intrinsic resistance to low triclosan levels in Pseudomonas aeruginosa. Int. J. Antimicrob. Agents. 26, 159\u2013164 (2005).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"36386_CR32","doi-asserted-by":"publisher","first-page":"e40319","DOI":"10.1371\/journal.pone.0040319","volume":"7","author":"S Hasan","year":"2012","unstructured":"Hasan, S., Danishuddin, M., Adil, M., Singh, K. & Verma, P. K. Efficacy of E. officinalis on the cariogenic properties of Streptococcus mutans: a novel and alternative approach to suppress quorum-sensing mechanism. PLoS One. 7, e40319 (2012).","journal-title":"PLoS One"},{"key":"36386_CR33","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/ijms21031003","volume":"21","author":"S Guan","year":"2020","unstructured":"Guan, S. et al. Exploration of binding mechanism of a potential Streptococcus pneumoniae neuraminidase inhibitor from herbaceous plants by molecular simulation. Int. J. Mol. Sci. 21, 1003. https:\/\/doi.org\/10.3390\/ijms21031003 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"36386_CR34","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1111\/jcmm.13179","volume":"21","author":"M Song","year":"2017","unstructured":"Song, M. et al. Epigallocatechin gallate inhibits Streptococcus pneumoniae virulence by simultaneously targeting Pneumolysin and sortase A. J. Cell. Mol. Med. 21, 2586\u20132598. https:\/\/doi.org\/10.1111\/jcmm.13179 (2017).","journal-title":"J. Cell. Mol. Med."},{"key":"36386_CR35","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.3390\/molecules27165063","volume":"27","author":"Q Sheng","year":"2022","unstructured":"Sheng, Q. et al. Corilagin: A novel antivirulence strategy to alleviate Streptococcus pneumoniae infection by diminishing Pneumolysin oligomers. Molecules 27, 5063. https:\/\/doi.org\/10.3390\/molecules27165063 (2022).","journal-title":"Molecules"},{"key":"36386_CR36","doi-asserted-by":"publisher","first-page":"1478135","DOI":"10.3389\/fphar.2024.1478135","volume":"15","author":"Y Li","year":"2024","unstructured":"Li, Y., Wu, H., Hu, Y., Meng, H. & Xu, Y. Glycyrol targets Pneumolysin (PLY) oligomerization to reduce Streptococcus pneumoniae toxicity. Front. Pharmacol. 15, 1478135. https:\/\/doi.org\/10.3389\/fphar.2024.1478135 (2024).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36386-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36386-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36386-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T22:02:30Z","timestamp":1770760950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36386-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36386"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36386-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5640"}}